Home / Inspections / 1119160

1119160

Apertus Pharmaceuticals — FEI 3010401502

Inspection Details

Classification: Voluntary Action Indicated (VAI) (VAI)
End Date: January 16, 2020
Fiscal Year: 2020
Product Type: Drugs
Project Area: Drug Quality Assurance
Location: Ballwin, MO (United States)